Industry Standards Group, Align Biopharma, Expands To 23 Members

By Bio-IT World Staff

July 13, 2017 | Align Biopharma today introduced 14 leading biopharma companies and technology and service providers as new members. In six months since it was formed, Align Biopharma has become a fast-growing influence in the industry to create and implement open technology standards. The group now includes a total of 23 members dedicated to making it easier for healthcare professionals (HCPs) to connect digitally with life sciences companies.

In addition to life sciences companies as members, Align Biopharma now includes technology providers, Adobe, Exostar, Gigya, Janrain, and Okta, and service providers Accenture, Cognizant, Deloitte, and Mavens. These leading companies are helping to define and review Align Biopharma’s open technology standards to ensure broad industry adoption.

“Align Biopharma has seen an overwhelming response from across the industry,” said Henry Levy, president of Align Biopharma, in a press release. “It’s clear there is a significant opportunity to improve the digital experience for healthcare professionals. We’re attracting the best experts that are shaping the standards to simplify how HCPs get the important treatment information they need.”

Align Biopharma’s first standard is for identity management. Expected available in summer 2017, the standard defines the technical requirements for solutions that provide a single sign-on service for HCPs. Align Biopharma has also begun development of its second standard for consent and preference management, which will enable consistency in how healthcare professionals specify communication preferences with each life sciences company. Align Biopharma expects to post its consent and preference management standard for public review and input later this year.